Kymera Therapeutics KYMR Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kymera Therapeutics's interest paid?
- Kymera Therapeutics (KYMR) reported interest paid of $65K in Q1 2026.
- How has Kymera Therapeutics's interest paid changed year-over-year?
- Kymera Therapeutics's interest paid decreased by 15.6% year-over-year, from $77K to $65K.
- What is the long-term trend for Kymera Therapeutics's interest paid?
- Over 4 years (2021 to 2025), Kymera Therapeutics's interest paid has grown at a 18.5% compound annual growth rate (CAGR), from $158K to $312K.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.